Gara Jalqabaatti › Kansaar Onnee Triple-Negative › New York › Queens
Qorannoo klinikaalii Kansaar Onnee Triple-Negative Queens, NY keessatti
Qorannoo 15 Kansaar Onnee Triple-Negative f Queens fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- START New York Long Island LLC, Lake Success · Miili 9 fagaatti
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer
Namoota walitti qabaa jiraSadarkaa 1
- NYU Langone Hospital - Long Island, Mineola · Miili 11 fagaatti
Study of AVZO-021 in Patients With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Avenzo Therapeutics Recruiting Site, Mineola · Miili 11 fagaatti
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Namoota walitti qabaa jiraSadarkaa 3
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0073), Mineola · Miili 11 fagaatti
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Namoota walitti qabaa jiraSadarkaa 3
- Clinical Research Alliance ( Site 0086), Westbury · Miili 14 fagaatti
A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · Miili 10 fagaatti
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · Miili 13 fagaatti
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Namoota walitti qabaa jiraSadarkaa 3
- Northwell Health, Lake Success · Miili 9 fagaatti
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NYU Langone Health - Long Island, Mineola · Miili 11 fagaatti
A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Memorial Sloan Kettering at Nassau (Limited Protocol Activities), Uniondale · Miili 13 fagaatti
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Namoota walitti qabaa jiraSadarkaa 2/3
- Clinical Research Alliance, Westbury · Miili 14 fagaatti
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Namoota walitti qabaa jiraSadarkaa 1
- START New York Long Island, LLC, Lake Success · Miili 9 fagaatti
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Namoota walitti qabaa jiraSadarkaa 2
- Memorial Sloan Kettering Nassau, Uniondale · Miili 13 fagaatti
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · Miili 13 fagaatti
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Clinical Research Alliance, Westbury · Miili 14 fagaatti
Qorannoo Kansaar Onnee Triple-Negative magaalota biroo keessatti
- Houston, TXQorannoo 42
- New York City, NYQorannoo 31
- Nashville, TNQorannoo 28
- Los Angeles, CAQorannoo 27
- Boston, MAQorannoo 26
- San Antonio, TXQorannoo 23
- St. Louis, MOQorannoo 21
- Arlington, VAQorannoo 20
- Atlanta, GAQorannoo 20
- Dallas, TXQorannoo 18
- Chicago, ILQorannoo 16
- Columbus, OHQorannoo 16
Qorannoo biroo Queens keessatti
- Saree OljooQorannoo 64
- Kansara Qara'a Non-Small CellQorannoo 49
- Kansarii ColorectalQorannoo 31
- Kansara MetastatikiiQorannoo 28
- Kansarii OvariiQorannoo 28
- Kansarii ProstateQorannoo 27
- Saree (Gosoota Hunda)Qorannoo 26
- Kansa EndometiriyaaliiQorannoo 25
- Dhibee QaraQorannoo 22
- Leukemia Myeloidii HamaaQorannoo 21
- Myeloma Baay’eeQorannoo 20
- Kansarii PancreasQorannoo 20
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.